ENST00000265724.8:c.-330-1017T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000265724.8(ABCB1):​c.-330-1017T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0514 in 151,796 control chromosomes in the GnomAD database, including 209 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.051 ( 209 hom., cov: 32)

Consequence

ABCB1
ENST00000265724.8 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.37

Publications

4 publications found
Variant links:
Genes affected
ABCB1 (HGNC:40): (ATP binding cassette subfamily B member 1) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000265724.8, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.04).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0838 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000265724.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCB1
NM_001348945.2
c.27+865T>C
intron
N/ANP_001335874.1
ABCB1
NM_000927.5
c.-330-1017T>C
intron
N/ANP_000918.2
ABCB1
NM_001348944.2
c.-183-1017T>C
intron
N/ANP_001335873.1P08183-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCB1
ENST00000265724.8
TSL:1
c.-330-1017T>C
intron
N/AENSP00000265724.3P08183-1
ABCB1
ENST00000961093.1
c.-183-1017T>C
intron
N/AENSP00000631152.1
ABCB1
ENST00000543898.5
TSL:5
c.-330-1017T>C
intron
N/AENSP00000444095.1P08183-2

Frequencies

GnomAD3 genomes
AF:
0.0512
AC:
7770
AN:
151678
Hom.:
204
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0858
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.0336
Gnomad ASJ
AF:
0.0219
Gnomad EAS
AF:
0.0498
Gnomad SAS
AF:
0.0313
Gnomad FIN
AF:
0.0343
Gnomad MID
AF:
0.0478
Gnomad NFE
AF:
0.0402
Gnomad OTH
AF:
0.0581
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0514
AC:
7801
AN:
151796
Hom.:
209
Cov.:
32
AF XY:
0.0502
AC XY:
3722
AN XY:
74204
show subpopulations
African (AFR)
AF:
0.0862
AC:
3570
AN:
41416
American (AMR)
AF:
0.0336
AC:
512
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.0219
AC:
76
AN:
3466
East Asian (EAS)
AF:
0.0499
AC:
256
AN:
5132
South Asian (SAS)
AF:
0.0314
AC:
151
AN:
4814
European-Finnish (FIN)
AF:
0.0343
AC:
360
AN:
10506
Middle Eastern (MID)
AF:
0.0514
AC:
15
AN:
292
European-Non Finnish (NFE)
AF:
0.0402
AC:
2731
AN:
67894
Other (OTH)
AF:
0.0585
AC:
123
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
377
754
1131
1508
1885
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0453
Hom.:
29
Bravo
AF:
0.0517

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.15
DANN
Benign
0.13
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs28746504;
hg19: chr7-87231411;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.